Eterna Therapeutics's total assets for Q were $7.72M, a decrease of -83.40% from the previous quarter. ERNA total liabilities were $53.11M for the fiscal quarter, a -3.46% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.